Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Di M Jiang

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
JCO Oncology Practice|February 12, 2020
Application of the ASCO Value Framework and ESMO Magnitude of Clinical Benefit Scale to Assess the Value of Abiraterone and Enzalutamide in Advanced Prostate CancerSarah E Wong, Louis Everest, Di M Jiang, et al.
Cancer Medicine|March 5, 2020
Surveillance and outcomes after curative resection for gastroesophageal adenocarcinomaDi M Jiang, Chihiro Suzuki, Osvaldo Espin-Garcia, et al.
Cancer Medicine|July 13, 2021
Clinicopathologic factors that influence prognosis and survival outcomes in men with metastatic castration-resistant prostate cancer treated with Radium-223Esmail M Al-Ezzi, Husam A Alqaisi, Marco A J Iafolla, et al.
Journal of Gastrointestinal Oncology|May 14, 2020
Impact of adjuvant therapy in patients with a microscopically positive margin after resection for gastric and esophageal cancersLucy X Ma, Osvaldo Espin-Garcia, Charles H Lim, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
JCO Oncology Practice|February 12, 2020
Application of the ASCO Value Framework and ESMO Magnitude of Clinical Benefit Scale to Assess the Value of Abiraterone and Enzalutamide in Advanced Prostate CancerSarah E Wong, Louis Everest, Di M Jiang, et al.
Cancer Medicine|March 5, 2020
Surveillance and outcomes after curative resection for gastroesophageal adenocarcinomaDi M Jiang, Chihiro Suzuki, Osvaldo Espin-Garcia, et al.
Cancer Medicine|July 13, 2021
Clinicopathologic factors that influence prognosis and survival outcomes in men with metastatic castration-resistant prostate cancer treated with Radium-223Esmail M Al-Ezzi, Husam A Alqaisi, Marco A J Iafolla, et al.
Journal of Gastrointestinal Oncology|May 14, 2020
Impact of adjuvant therapy in patients with a microscopically positive margin after resection for gastric and esophageal cancersLucy X Ma, Osvaldo Espin-Garcia, Charles H Lim, et al.
Pageof 1